Alan Go to Coronary Disease
This is a "connection" page, showing publications Alan Go has written about Coronary Disease.
Connection Strength
4.361
-
High-sensitivity cardiac troponin I and incident coronary heart disease among asymptomatic older adults. Heart. 2016 08 01; 102(15):1177-82.
Score: 0.504
-
Reply: Beta-blockers for angina: time to reassess the specific impact of drug therapy in coronary heart disease patients. J Am Coll Cardiol. 2014 Dec 23; 64(24):2712.
Score: 0.462
-
Impact of drug-eluting stents on the comparative effectiveness of coronary artery bypass surgery and percutaneous coronary intervention. Am Heart J. 2015 Jan; 169(1):149-54.
Score: 0.457
-
Acute kidney injury after CABG versus PCI: an observational study using 2 cohorts. J Am Coll Cardiol. 2014 Sep 09; 64(10):985-94.
Score: 0.453
-
Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention. J Am Coll Cardiol. 2013 Jan 22; 61(3):295-301.
Score: 0.401
-
Chronic kidney disease and risk for presenting with acute myocardial infarction versus stable exertional angina in adults with coronary heart disease. J Am Coll Cardiol. 2011 Oct 04; 58(15):1600-7.
Score: 0.369
-
Value of the sagittal abdominal diameter in coronary heart disease risk assessment: cohort study in a large, multiethnic population. Am J Epidemiol. 2006 Dec 15; 164(12):1150-9.
Score: 0.262
-
A systematic review of the effects of physician specialty on the treatment of coronary disease and heart failure in the United States. Am J Med. 2000 Feb 15; 108(3):216-26.
Score: 0.165
-
Heterogeneity in national U.S. mortality trends within heart disease subgroups, 2000-2015. BMC Cardiovasc Disord. 2017 07 18; 17(1):192.
Score: 0.138
-
Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population. J Am Coll Cardiol. 2016 05 10; 67(18):2118-2130.
Score: 0.127
-
Metabolic Dyslipidemia and Risk of Coronary Heart Disease in 28,318 Adults With Diabetes Mellitus and Low-Density Lipoprotein Cholesterol <100 mg/dl. Am J Cardiol. 2015 Dec 01; 116(11):1700-4.
Score: 0.121
-
Challenges of ascertaining national trends in the incidence of coronary heart disease in the United States. J Am Heart Assoc. 2014 Dec 03; 3(6):e001097.
Score: 0.115
-
ß-blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease. J Am Coll Cardiol. 2014 Jul 22; 64(3):247-52.
Score: 0.112
-
Population trends from 2000-2011 in nuclear myocardial perfusion imaging use. JAMA. 2014 Mar 26; 311(12):1248-9.
Score: 0.110
-
Risk factors for coronary artery calcium among patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort Study). Am J Cardiol. 2012 Dec 15; 110(12):1735-41.
Score: 0.099
-
Racial variation in lipoprotein-associated phospholipase A2 in older adults. BMC Cardiovasc Disord. 2011 Jun 29; 11:38.
Score: 0.091
-
Insulin resistance independently predicts the progression of coronary artery calcification. Am Heart J. 2009 May; 157(5):939-45.
Score: 0.078
-
Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease. Am Heart J. 2007 Dec; 154(6):1035-42.
Score: 0.070
-
Clinical utility of the Stanford brief activity survey in men and women with early-onset coronary artery disease. J Cardiopulm Rehabil Prev. 2007 Jul-Aug; 27(4):227-32.
Score: 0.069
-
Reducing delay in seeking treatment by patients with acute coronary syndrome and stroke: a scientific statement from the American Heart Association Council on cardiovascular nursing and stroke council. Circulation. 2006 Jul 11; 114(2):168-82.
Score: 0.064
-
Breast vascular calcification and risk of coronary heart disease, stroke, and heart failure. J Womens Health (Larchmt). 2004 May; 13(4):381-9; discussion 390-2.
Score: 0.055
-
Association Between Aging of the US Population and Heart Disease Mortality From 2011 to 2017. JAMA Cardiol. 2019 12 01; 4(12):1280-1286.
Score: 0.041